IYH vs XLV

Key Takeaways

• Both IYH and XLV provide targeted exposure to the U.S. healthcare sector through passive, market-capitalization-weighted strategies focused on pharmaceuticals, biotechnology, and related industries.
• IYH tracks the Russell 1000 Health Care RIC 22.5/45 Capped Index with approximately 100 holdings and an expense ratio of 0.38%, offering broader diversification across mid- and large-cap healthcare names.
• XLV tracks the Health Care Select Sector Index with around 62 holdings and a lower expense ratio of 0.08%, concentrating on large-cap constituents of the S&P 500 healthcare sector.
• Top holdings overlap significantly in both ETFs, led by Eli Lilly (LLY), Johnson & Johnson (JNJ), and AbbVie (ABBV), though XLV exhibits greater concentration in its largest positions.
• IYH delivers slightly wider exposure to smaller healthcare firms within its index universe, while XLV emphasizes cost efficiency and liquidity typical of S&P 500 sector products.
• Structural differences center on index construction, number of holdings, and fee levels, influencing relative diversification and long-term cost profiles rather than short-term market timing.

Introduction

Investors seeking U.S. healthcare sector exposure often compare IYH and XLV because both ETFs deliver passive access to the same broad industry without active management or leverage. They do not compete directly as substitutes but instead offer alternative approaches within healthcare: one emphasizing broader Russell 1000 representation and the other focusing on S&P 500 large-cap names. This comparison helps clarify trade-offs in diversification, costs, and structural characteristics amid ongoing sector developments such as innovation in pharmaceuticals and demographic-driven demand for healthcare services.

iShares U.S. Healthcare ETF (IYH) Overview

The iShares U.S. Healthcare ETF seeks to track the Russell 1000 Health Care RIC 22.5/45 Capped Index, which measures the performance of U.S. equities in the healthcare sector. The fund holds approximately 100 securities and maintains a passive, market-capitalization-weighted approach with periodic rebalancing to reflect index changes. Top holdings typically include Eli Lilly (LLY), Johnson & Johnson (JNJ), AbbVie (ABBV), Merck (MRK), and UnitedHealth Group (UNH). Sector allocations concentrate in pharmaceuticals, biotechnology, health care equipment, and life sciences tools & services. The expense ratio stands at 0.38%. Distinguishing features include coverage of a wider range of healthcare companies compared with S&P 500-restricted peers, supporting moderately broader diversification within the sector.

State Street Health Care Select Sector SPDR ETF (XLV) Overview

The State Street Health Care Select Sector SPDR ETF seeks to provide investment results that correspond generally to the Health Care Select Sector Index, a subset of the S&P 500 Index. The fund holds approximately 62 securities and employs a passive, market-capitalization-weighted methodology with regular index-aligned rebalancing. Top holdings commonly feature Eli Lilly (LLY), Johnson & Johnson (JNJ), AbbVie (ABBV), UnitedHealth Group (UNH), and Merck (MRK). Allocations center on pharmaceuticals, biotechnology, health care providers & services, and health care equipment & supplies. The expense ratio is 0.08%. Key structural characteristics include high liquidity, tight tracking to large-cap healthcare names, and cost efficiency derived from its S&P 500 sector focus.

Industry and Thematic Backdrop

The U.S. healthcare sector encompasses pharmaceuticals, biotechnology, medical devices, and providers, driven by long-term demographic trends such as aging populations and rising chronic disease prevalence. Recent market cycles have highlighted innovation in areas like weight-loss therapeutics and oncology as catalysts, alongside regulatory considerations around drug pricing and patent expirations. Macroeconomic factors including interest rate environments and capital flows into growth-oriented subsectors continue to influence the space. Both ETFs remain positioned to capture these durable themes while navigating risks such as policy shifts and competitive pressures within the industry.

Performance and Positioning Comparison

In recent market cycles, the two ETFs have exhibited broadly aligned behavior tied to healthcare earnings trends and sector rotation patterns, with differences stemming from their distinct index universes. IYH’s broader holdings can moderate volatility relative to more concentrated large-cap exposure during periods of dispersion among healthcare sub-industries. XLV’s lower expense ratio and tighter focus on S&P 500 constituents support efficient participation in large-cap momentum. Relative positioning reflects trade-offs between diversification breadth and cost efficiency, with both funds responding to common drivers such as earnings growth in leading pharmaceutical and biotechnology companies.

AI Screener

Tickeron’s AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener helps identify trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. Explore the AI Screener to refine your healthcare sector analysis.

Tickeron AI Verdict

Based on observable structural factors, Tickeron’s AI would likely assign a modest probabilistic preference to XLV in the current environment due to its substantially lower expense ratio, strong liquidity profile, and efficient large-cap concentration. IYH offers value for investors prioritizing wider diversification across additional healthcare names. The choice ultimately depends on an investor’s emphasis on cost efficiency versus breadth within the same thematic sector.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations